Our research not only enhanced the understanding of the relationship between IDO1 and angiogenesis in glioma in terms of mechanism but also proposed the promising strategy of combining an IDO1 inhibitor with an angiogenesis inhibitor for glioma treatment. This evidence concerns the gene IDO1 and glioma.